Skip to main content
Lonza Group AG logo

Lonza Group AG — Investor Relations & Filings

Ticker · LONN ISIN · CH1255014495 LEI · 549300EFW4H2TCZ71055 SW Manufacturing
Open in API
Filings indexed 137 across all filing types
Latest filing 2023-09-18 Board/Management Inform…
Country CH Switzerland
Listing SW LONN

About Lonza Group AG

https://www.lonza.com/

Lonza Group AG is a global contract development and manufacturing organization (CDMO) that partners with the pharmaceutical, biotech, and nutrition industries. The company provides integrated services that span the entire product lifecycle, from early-phase research and process development to custom, large-scale commercial manufacturing. Its expertise covers a wide range of therapeutic modalities, including mammalian and microbial biopharmaceuticals, small molecules, cell and gene therapies, highly potent active pharmaceutical ingredients (APIs), peptides, and bioconjugates. By combining advanced scientific and technological insights with world-class manufacturing and regulatory expertise, Lonza supports its customers in developing and commercializing innovative medicines and health products for patients worldwide.

Recent filings

Filing Released Lang Actions
Mitteilung des Verwaltungsrats
Board/Management Information Classification · 100% confidence The document is titled "Ad hoc-Mitteilung gemäss Art. 53 KR" (Ad hoc announcement according to Art. 53 KR) and explicitly announces a change in senior management: the CEO, Pierre-Alain Ruffieux, is leaving, and the Chairman of the Board, Albert M. Baehny, is taking over as interim CEO. This directly corresponds to the definition of Board/Management Information (MANG). Although it is an official announcement, the content is substantive (management change) rather than just announcing the publication of another report (which would suggest RPA or RNS). Since the core subject is the change in senior management, MANG is the most specific classification.
2023-09-18 German
Lonza Delivers 5.6% CER Sales Growth, With Underlying Growth at Around 10% CER and 30% CORE EBITDA Margin
Earnings Release Classification · 100% confidence The document is explicitly titled as an 'Ad hoc announcement pursuant to Art. 53 LR' and contains key financial highlights for 'Half Year Results' (H1 2023), including sales figures, EBITDA margin, and updated guidance. This structure—a brief announcement summarizing period results and outlook—is characteristic of an Earnings Release (ER). Although it mentions links to the 'Half-Year 2023 Report' and 'Presentation', the document itself is the initial summary release, not the comprehensive report (which would be classified as IR). Since it covers a period shorter than a year ('Half Year'), it is not a 10-K. It is the primary announcement of period results. H1 2023
2023-07-21 English
Lonza Delivers 5.6% CER Sales Growth, With Underlying Growth at Around 10% CER and 30% CORE EBITDA Margin
Earnings Release Classification · 100% confidence The document is titled 'Ad hoc announcement pursuant to Art. 53 LR' and explicitly details financial results for 'H1 2023' (First Half 2023), including sales figures, CORE EBITDA margin, and an updated Group Outlook for 2023. This content structure—a summary of period results, divisional performance, and guidance updates—is characteristic of an Earnings Release (ER). Although it references a 'Half-Year 2023 Report' and 'Presentation' at the end, the document itself is the initial, brief announcement summarizing these results, which aligns perfectly with the definition of an Earnings Release (ER). It is not the comprehensive Interim/Quarterly Report (IR) itself, but the initial release of the results. H1 2023
2023-07-21 English
Lonza erzielt ein Umsatzwachstum von 5.6% (kWk) mit zugrunde liegendem Wachstum von rund 10% (kWk) und eine Kern-EBITDA-Marge von 30%
Earnings Release Classification · 100% confidence The document is titled 'Ad hoc-Mitteilung gemäss Art. 53 KR' (Ad hoc announcement according to Art. 53 KR) and explicitly reports on the 'Halbjahresergebnis' (Half-year result) for the first half of 2023, detailing revenue, EBITDA margin, and providing an updated outlook for 2023. This content structure—a summary of period financial results, operational highlights, and outlook adjustments—is characteristic of an Earnings Release (ER) or an Interim/Quarterly Report (IR). Since it provides the key financial figures and management commentary for a period shorter than a year (H1 2023), it fits the definition of an Interim / Quarterly Report (IR). Although it is an 'Ad hoc-Mitteilung' (a regulatory disclosure mechanism in Switzerland), the substance is the comprehensive half-year financial performance summary, making IR the most accurate classification over the general Regulatory Filing (RNS) or the initial highlights-only Earnings Release (ER). The document length (9680 chars) is substantial enough to be the report itself, not just a brief announcement of a report. H1 2023
2023-07-21 German
Lonza to Acquire Synaffix and Strengthen Antibody-Drug Conjugates Offering
M&A Activity Classification · 99% confidence The document is a press release dated June 1, 2023, announcing that Lonza Group AG is acquiring Synaffix B.V. The key phrases are "Lonza to Acquire Synaffix" and "Key word(s): Acquisition/Mergers & Acquisitions". This clearly indicates a corporate transaction announcement. Reviewing the filing definitions, the most appropriate category for an announcement regarding a merger or takeover bid is 'M&A Activity' (Code: TAR). It is not a full financial report (10-K, IR), an earnings release (ER), or a general regulatory filing (RNS), as it describes a specific corporate action.
2023-06-01 English
Lonza to Acquire Synaffix and Strengthen Antibody-Drug Conjugates Offering
M&A Activity Classification · 99% confidence The document is a press release dated June 1, 2023, announcing that Lonza Group AG is acquiring Synaffix B.V. The key subject matter is an acquisition/merger, explicitly mentioned in the title ('Lonza to Acquire Synaffix') and the body text. This directly corresponds to the M&A Activity category. The code for M&A Activity is TAR (Takeover/Acquisition/Merger). The document is a formal announcement of a transaction, not a regulatory filing like a 10-K or a general regulatory notice (RNS).
2023-06-01 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.